Search research articles
Contact Us
Filters
Showing results (201-210 of 223) with videos related to
Page
of 23
Sort By:
Pediatric Blood & Cancer
|
January 20, 2025
Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial
Roberto Luksch, Emanuela Palmerini, Giuseppe Maria Milano, et al.
Cancer Communications (London, England)
|
March 16, 2026
IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma Cohort
Javier Martin-Broto, Sandra J Strauss, Emanuela Palmerini, et al.
Cancer
|
February 24, 2022
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)
Emanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
Scientific Reports
|
April 16, 2016
Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases
Daniele Santini, Sandro Barni, Salvatore Intagliata, et al.
Frontiers in Oncology
|
July 14, 2020
Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group
Dominga Racanelli, Monica Brenca, Davide Baldazzi, et al.
Frontiers in Oncology
|
May 1, 2020
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group
Dominga Racanelli, Monica Brenca, Davide Baldazzi, et al.
Critical Reviews in Oncology/Hematology
|
May 8, 2026
Management of Atypical Cartilaginous Tumors (ACT) An Italian Sarcoma Group Consensus Document
Domenico A Campanacci, Giacomo Giulio Baldi, Roberto Scanferla, et al.
Tumori
|
September 15, 2025
The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives
Alberto Zambelli, Riccardo Gerosa, Michela Cinquini, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 6, 2015
Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
Matteo Santoni, Alessandro Conti, Giuseppe Procopio, et al.
Critical Reviews in Oncology/Hematology
|
June 27, 2026
Corrigendum to "Management of atypical cartilaginous tumors (ACT): An Italian Sarcoma Group (ISG) consensus document" [Crit. Rev. Oncol. Hematol. 223 (2026) 105358]
Domenico Andrea Campanacci, Giacomo Giulio Bald, Roberto Scanferla, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 223) with videos related to
Sort By:
Page
of 23
Pediatric Blood & Cancer
|
January 20, 2025
Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial
Roberto Luksch, Emanuela Palmerini, Giuseppe Maria Milano, et al.
Cancer Communications (London, England)
|
March 16, 2026
IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma Cohort
Javier Martin-Broto, Sandra J Strauss, Emanuela Palmerini, et al.
Cancer
|
February 24, 2022
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)
Emanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
Scientific Reports
|
April 16, 2016
Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases
Daniele Santini, Sandro Barni, Salvatore Intagliata, et al.
Frontiers in Oncology
|
July 14, 2020
Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group
Dominga Racanelli, Monica Brenca, Davide Baldazzi, et al.
Frontiers in Oncology
|
May 1, 2020
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group
Dominga Racanelli, Monica Brenca, Davide Baldazzi, et al.
Critical Reviews in Oncology/Hematology
|
May 8, 2026
Management of Atypical Cartilaginous Tumors (ACT) An Italian Sarcoma Group Consensus Document
Domenico A Campanacci, Giacomo Giulio Baldi, Roberto Scanferla, et al.
Tumori
|
September 15, 2025
The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives
Alberto Zambelli, Riccardo Gerosa, Michela Cinquini, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 6, 2015
Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
Matteo Santoni, Alessandro Conti, Giuseppe Procopio, et al.
Critical Reviews in Oncology/Hematology
|
June 27, 2026
Corrigendum to "Management of atypical cartilaginous tumors (ACT): An Italian Sarcoma Group (ISG) consensus document" [Crit. Rev. Oncol. Hematol. 223 (2026) 105358]
Domenico Andrea Campanacci, Giacomo Giulio Bald, Roberto Scanferla, et al.
Page
of 23